Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

APO-PROPAFENONE 300 MG

PROPAFENONE HYDROCHLORIDE : 300 MG · DIN 02243325 · APOTEX INC

Health Canada status: MARKETED

What is APO-PROPAFENONE?

APO-PROPAFENONE 300 MG contains PROPAFENONE HYDROCHLORIDE : 300 MG. It is listed in the Health Canada Drug Product Database under DIN 02243325, held by APOTEX INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 31-Aug-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is APO-PROPAFENONE used for?

APO-PROPAFENONE (propafenone hydrochloride) is indicated for the treatment of documented life-threatening ventricular arrhythmias, such as sustained ventricular tachycardia prevention. It may also be used for documented symptomatic ventricular arrhythmias when symptoms require treatment, only if the benefit outweighs the risks due to proarrhythmic effects.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN02243325
Brand nameAPO-PROPAFENONE
Generic / active ingredientPROPAFENONE HYDROCHLORIDE : 300 MG
ManufacturerAPOTEX INC
Strength300 MG
Dosage formTABLET
Route of administrationORAL
SchedulePrescription
ATC codeC01BC03 PROPAFENONE
AHFS class24:04.04.12
BiosimilarNo
Health Canada statusMARKETED
Status date31-Aug-2018
Original market date2001-02-22 00:00:00

How is it stored and handled?

null

How is it supplied?

APO - PROPAFENONE 150 mg: bottles of 100 and 500. APO - PROPAFENONE 300 mg: bottles of 100 and 500.

What can be used instead?

Other Canadian products sharing ATC code C01BC03 PROPAFENONE. 6 of 19 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
APO-PROPAFENONE150 MGTABLETAPOTEX INCMARKETEDDIN 02243324
MYLAN-PROPAFENONE150 MGTABLETMYLAN PHARMACEUTICALS ULCMARKETEDDIN 02457172
MYLAN-PROPAFENONE300 MGTABLETMYLAN PHARMACEUTICALS ULCMARKETEDDIN 02457164
RYTHMOL150 MGTABLETBGP PHARMA ULCMARKETEDDIN 00603708
RYTHMOL300 MGTABLETBGP PHARMA ULCMARKETEDDIN 00603716
MYL-PROPAFENONE150 MGTABLETMYLAN PHARMACEUTICALS ULCCANCELLED POST MARKETDIN 02245372
MYL-PROPAFENONE300 MGTABLETMYLAN PHARMACEUTICALS ULCCANCELLED POST MARKETDIN 02245373
NU-PROPAFENONE150 MGTABLETNU-PHARM INCCANCELLED (UNRETURNED ANNUAL)DIN 02249480
PMS-PROPAFENONE150 MGTABLETPHARMASCIENCE INCCANCELLED POST MARKETDIN 02243727
PMS-PROPAFENONE150 MGTABLETPHARMASCIENCE INCCANCELLED PRE MARKETDIN 02466155

Who else supplies PROPAFENONE worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. PROPAFENONE appears in 49 registered pack listings across 8 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for APO-PROPAFENONE

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for APO-PROPAFENONE

Health Canada Drug Product Database (DPD), DIN 02243325. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.